Scientists have identified about two dozen genes that control embryonic stem cell fate. The genes may either prod or restrain stem cells from drifting into a kind of limbo, they suspect. The limbo lies between the embryonic stage and fully differentiated, or specialized, cells, such as bone, muscle or fat.

By knowing the genes and proteins that control a cell's progress toward the differentiated form, researchers may be able to accelerate the process – a potential boon for the use of stem cells in therapy or the study of some degenerative diseases, the scientists say.

Their finding comes from the first large-scale search for genes crucial to embryonic stem cells. The research was carried out by a team at the University of California, San Francisco and is reported in a paper in the July 11, 2008 issue of Cell.

WALTHAM, Massachusetts, July 10 /PRNewswire/ --

Usman Ismail, executive vice president of international sales and business development of Lewtan Technologies, Inc.(R), provider of asset-backed securities surveillance, analytics, and content for the global securitization industry, today announced the promotion of Jamie Harper to vice president of European, Middle Eastern and African regions (EMEA).

REDWOOD CITY, California, July 10 /PRNewswire/ --

- Cache poisoning vulnerability requires immediate action to deter Internet exploits

Nominum, the leading provider of network naming and addressing technologies, announced that latest versions of it's Caching Name Server and Vantio Base Server software meet and exceed the tightened DNS security measures required to address a new DNS security threat announced by the United States Computer Emergency Readiness Team (US-CERT) Vulnerability notice number 800113 on July 8th, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20000511/SFTH101LOGO)

Kombucha starts with a mushroom, but this is not a real mushroom it’s actually the skin that forms over the top of fermenting tea after it’s combined with yeast and the bacteria Acetobacter. Once the tea ferments in about one week, it has successfully become the much loved kombucha tea. In order for the tea to ferment sugar needs to be added and the bacteria can be used to ferment other liquids as well.

SAINT CHARLES, Minnesota, July 9 /PRNewswire/ --

SmoothToe, the only brand of diabetic socks available anywhere in the world with a Lifetime Blister Free Guarantee as well as a Five Year Extended Warranty, has new owners and is expanding internationally.

Lifestyle Medical Group LLC (http://www.SmoothToe-Socks.com) is pleased to announce its April 1st 2008 acquisition of the SmoothToe brand of diabetic socks and their introduction to the UK via the website: http://www.SmoothToe.co.uk.

"The expansion into the UK market with the SmoothToe brand is a natural extension of our comprehensive online marketing plan," said Greg Hoscheit, partner at Lifestyle Medical Group.

COPENHAGEN, Denmark, July 9 /PRNewswire/ -- Summary: Genmab has completed recruitment of patients in the Phase II study of ofatumumab in combination with fludarabine and cyclophosphamide to treat front line CLL.

Genmab A/S (OMX: GEN) announced today it has completed recruitment of 56 patients in the Phase II study of ofatumumab (HuMax-CD20 (R)) in combination with fludarabine and cyclophosphamide (FC) to treat chronic lymphocytic leukemia (CLL) in previously untreated patients.

"We are pleased to complete patient enrollment in the first front line study of ofatumumab and hope to see a positive outcome for the CLL patients in this trial," said Lisa N. Drakeman, Ph.D., Chief Executive Officer of Genmab.

PLAINSBORO, New Jersey, July 9 /PRNewswire/ --

SAI Global, a leading provider of governance, risk and compliance (GRC) solutions, has expanded its portfolio of compliance and risk management services by purchasing the Privacy Knowledgebase (PKB) from Stone Investments, Inc.

CALGARY, Canada, July 9 /PRNewswire/ -- Resverlogix Corp's ("Resverlogix" or the "Company") (TSX:RVX) novel lead ApoA-I drug candidate, RVX-208 has been selected as one of the top 10 most promising cardiovascular disease (CVD) drugs available for strategic partnering by an independent committee assembled by Windhover Information, a leading provider of business information products and services to senior executives in the pharmaceutical, biotechnology, and medical device industries.

NEW YORK, July 9 /PRNewswire/ --

- GCI Health meets global needs for the increasingly complex healthcare environment

Cohn & Wolfe has announced the formation of GCI Health, a new global healthcare public relations firm, specializing in all aspects of the healthcare industry. GCI Health, which will be led by Jill Dosik as president, offers high-science expertise, ROI-generating product marketing strategy and leading-edge digital health capabilities. It is a Cohn & Wolfe Group company, but will operate independently.

AUSTIN, Texas, July 9 /PRNewswire/ -- Ringdale(R), Inc., a technology leader in network enhancing connectivity solutions, today announced the availability of FollowMe(R) 5.1, a significant update to its secure document output management solution. The FollowMe 5.1 release is comprised of the following new features for enhanced administrative and user capabilities: